Physician profile
John A Primomo
NPI 1437264728
$4,508.05
in general payments reported to CMS, 2019-2025
15 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,216 · 2020: $148 · 2021: $325 · 2022: $503 · 2023: $768 · 2024: $257 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.99 |
| Education | $170.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,215.28 | 2019 | |
| Ethicon US, LLC | $707.91 | 2019-2023 | Echelon Flex |
| Intuitive Surgical, INC. | $566.20 | 2021-2025 | Da Vinci Surgical System |
| Allergan, INC. | $426.19 | 2019-2020 | |
| Intra-Sana Laboratories | $332.07 | 2021-2022 | |
| Teleflex LLC | $318.44 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Baxter Healthcare | $241.09 | 2023-2025 | Perclot |
| W. L. Gore & Associates, INC. | $170.64 | 2019 | |
| Olympus America INC. | $143.22 | 2019 | |
| Phathom Pharmaceuticals, INC. | $125.01 | 2024 | Voquezna |
| Tela Bio, INC. | $95.87 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $95.44 | 2019 | |
| Novo Nordisk INC | $36.80 | 2024 | Wegovy |
| Boston Scientific Corporation | $20.25 | 2024 | Spyglass Discover |
| Standard Bariatrics, INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Primomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.